Search

Alnylam Pharmaceuticals Inc

Geschlossen

BrancheGesundheitswesen

280.94 0.44

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

279

Max

288.78

Schlüsselkennzahlen

By Trading Economics

Einkommen

20M

206M

Verkäufe

70M

1.2B

KGV

Branchendurchschnitt

78.851

60.549

EPS

1.99

Gewinnspanne

17.649

Angestellte

2,500

EBITDA

159M

304M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+60.8% upside

Dividenden

By Acuity

Nächstes Ergebnis

30. Juli 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

631M

42B

Vorheriger Eröffnungskurs

280.5

Vorheriger Schlusskurs

280.94

Nachrichtenstimmung

By Acuity

50%

50%

176 / 342 Ranking in Healthcare

Alnylam Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Juli 2026, 23:41 UTC

Correlated Moves
News
Macro News
ETF Constituents

Vanguard Information Technology ETF declined in after-market hours amid rising crude oil prices and negative sentiment from Oracle's losses, impacting major tech stocks.

13. Juli 2026, 23:26 UTC

News

Shares of Netflix are higher in after-market hours as options traders make bullish bets ahead of the earnings report on July 16.

13. Juli 2026, 23:16 UTC

News

Marriott International will release second-quarter 2026 earnings on August 3, 2026. Shares are higher in after-hours trading, though near the lower end of their range.

13. Juli 2026, 23:11 UTC

News

USD/THB is advancing in Monday's session, supported by a recovery from earlier lows. Rising inflation concerns are influencing market dynamics ahead of upcoming reports.

13. Juli 2026, 23:06 UTC

Social Media
News

Biogen received FDA approval for LEQEMBI IQLIK, a subcutaneous Alzheimer's treatment, boosting shares modestly higher in after-market trading.

13. Juli 2026, 22:51 UTC

News

Vanguard Mortgage-Backed Securities ETF is trading lower in after-market hours, influenced by rising crude oil prices and concerns over inflation and interest rates.

13. Juli 2026, 22:51 UTC

News

The USD/ZAR is trading higher amid geopolitical tensions following U.S. strikes against Iran, maintaining strength near its one-month range.

13. Juli 2026, 22:31 UTC

News
ETF Constituents

Vanguard Growth ETF trades higher in after-market hours, supported by Nvidia and Texas Instruments, amid rising crude oil prices and inflation concerns.

13. Juli 2026, 22:31 UTC

News
Correlated Moves

iShares 7-10 Year Treasury Bond ETF rises slightly after market close, amid rising crude oil prices and inflation concerns influencing broader market volatility.

13. Juli 2026, 22:21 UTC

News

Vanguard Total Bond Market ETF is modestly higher in after-market trading as crude oil prices rise amid escalating U.S.-Iran military tensions.

13. Juli 2026, 22:01 UTC

News

The USD/HUF is gaining, reaching a session high as rising oil prices heighten inflation concerns and potential Federal Reserve interest rate hikes.

13. Juli 2026, 21:51 UTC

Correlated Moves
News

The iShares 20+ Year Treasury Bond ETF is slightly higher in after-market trading as rising U.S. Treasury yields follow President Trump's Iranian blockade announcement.

13. Juli 2026, 20:21 UTC

Correlated Moves
News
ETF Constituents

The Russell 2000 Index is modestly lower after-market, reflecting broader market declines amid U.S.-Iran tensions. Vanguard Small-Cap ETF remains little changed.

13. Juli 2026, 20:07 UTC

Social Media
News

American Airlines Group shares are lower amid concerns over high debt and disappointing revenue passenger miles, despite some optimistic social media discussions.

13. Juli 2026, 20:07 UTC

News
Correlated Moves

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The cryptocurrency fell from an earlier session high.

13. Juli 2026, 20:07 UTC

Correlated Moves
News

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The asset remains above its 20-day moving average.

13. Juli 2026, 20:07 UTC

News
Correlated Moves
Social Media

The Polish zloty has weakened, contributing to a modest rise in USD/PLN since Friday's close amid increased military tensions and inflation concerns.

13. Juli 2026, 20:07 UTC

News
Correlated Moves

Silver/NZD declines amid rising inflation concerns linked to surging crude oil prices and fears of interest rate hikes. The asset has closed lower for three sessions.

13. Juli 2026, 20:07 UTC

Correlated Moves
News

Silver is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions. The asset has pulled back from earlier session gains.

13. Juli 2026, 20:07 UTC

News
Correlated Moves

Silver Ounce vs Euro is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions, marking three consecutive sessions lower.

13. Juli 2026, 20:07 UTC

Correlated Moves
News

Silver declines amid rising inflation concerns and crude oil price surge. The asset has pulled back from earlier gains, continuing a downward trend.

13. Juli 2026, 20:07 UTC

News
Correlated Moves

Silver declines amid rising inflation concerns linked to crude oil prices. The asset has pulled back from earlier gains and remains below its 20-day moving average.

13. Juli 2026, 20:07 UTC

News
Correlated Moves

USD/CZK is trading higher, supported by broader gains and approaching the upper end of its one-month range amid inflation data and Federal Reserve policy focus.

13. Juli 2026, 20:07 UTC

News
Correlated Moves

The US Dollar Index's rise supports USD/DKK, which is higher since Friday's close. Concerns over U.S.-Iran military actions impact market sentiment.

13. Juli 2026, 20:06 UTC

News

Fiserv shares are higher as leadership changes prompt analysts to monitor potential impacts. The company is also considering the sale of its STAR payment network.

13. Juli 2026, 20:06 UTC

News
Social Media

MercadoLibre opens a new distribution center in Nuevo León, Mexico, creating over 2,000 jobs and enhancing logistics amid rising e-commerce demand. Shares are higher.

13. Juli 2026, 20:06 UTC

News

Gold is trading higher, supported by inflation concerns linked to rising crude oil prices amid U.S.-Iran tensions. Silver has declined after earlier gains.

13. Juli 2026, 20:06 UTC

Correlated Moves
News

The USD/SGD is trading higher, reflecting strength near its one-month range. Broader market dynamics and geopolitical tensions are influencing currency movements.

13. Juli 2026, 20:06 UTC

Correlated Moves
News

The USD/SEK is trading higher, influenced by broader currency market movements and concerns over supply disruptions in the Strait of Hormuz.

13. Juli 2026, 20:06 UTC

News
Correlated Moves

Silver/JPY is declining amid rising inflation concerns linked to crude oil prices and escalating U.S.-Iran tensions. The asset has traded lower for three consecutive sessions.

Peer-Vergleich

Kursveränderung

Alnylam Pharmaceuticals Inc Prognose

Kursziel

By TipRanks

60.8% Vorteil

12-Monats-Prognose

Durchschnitt 463.19 USD  60.8%

Hoch 550 USD

Tief 400 USD

Basierend auf 20 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Alnylam Pharmaceuticals Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

20 ratings

19

Buy

1

Halten

0

Sell

Stimmung

By Acuity

176 / 342 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Alnylam Pharmaceuticals Inc

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
help-icon Live chat